Tue, March 19, 2024

Joseph Pantginis Maintained (ATNM) at Strong Buy and Held Target at $50 on, Mar 19th, 2024

Joseph Pantginis of HC Wainwright & Co., Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $50 on, Mar 19th, 2024.

Joseph has made no other calls on ATNM in the last 4 months.



There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Yuan Zhi of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $16 on, Monday, December 11th, 2023